Dr. Andrew M. Kaunitz on Considerations for Previvors in Addressing Menopausal Symptoms

Genetic testing decisions in patients with cancer may be affected by significant out-of-pocket costs.

Beth Sandy, MSN, CRNP, and Tajuana Bradley, MSN, APRN-BC, discuss the importance of molecular testing in non–small cell lung cancer.

Cheryl VerStrate, DNP, AGPCNP-BC, OCN, explains the pitfalls with at-home genomic tests and why nurses must be ready to talk to their patients about genetic counseling.

Oncology nurses make the case for nurse intervention with direct-to-consumer genomic testing.

Julie C. Martin DNP, AOCN, FNP-BC, discusses best practices to approaching conversations on clinically actionable genomic results with patients.

Findings from the TAPESTRY trial showed that approximately 40% of patients with genetic conditions may be missed by current NCCN guidelines.